488 related articles for article (PubMed ID: 11225134)
1. Target gland functional status in patients with non-Cushing's pituitary macroadenomas undergoing transsphenoidal microsurgery.
Garg MK; Tandon N; Gupta N; Varma A; Singh VP
J Assoc Physicians India; 2001 Feb; 49():221-6. PubMed ID: 11225134
[TBL] [Abstract][Full Text] [Related]
2. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
Mukherjee A; Murray RD; Teasdale GM; Shalet SM
Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
[TBL] [Abstract][Full Text] [Related]
3. Reversible hypopituitarism in patients with large nonfunctioning pituitary adenomas.
Arafah BM
J Clin Endocrinol Metab; 1986 Jun; 62(6):1173-9. PubMed ID: 3009521
[TBL] [Abstract][Full Text] [Related]
4. [Influence of hyperprolactinemia and tumoral size in the postoperative pituitary function in clinically nonfunctioning pituitary macroadenomas].
Fonseca AL; Chimelli L; Santos MJ; Santos AA; Violante AH
Arq Neuropsiquiatr; 2002 Sep; 60(3-A):590-602. PubMed ID: 12244397
[TBL] [Abstract][Full Text] [Related]
5. Recovery of visual and endocrine function following transsphenoidal surgery of large nonfunctioning pituitary adenomas.
Marazuela M; Astigarraga B; Vicente A; Estrada J; Cuerda C; García-Uría J; Lucas T
J Endocrinol Invest; 1994 Oct; 17(9):703-7. PubMed ID: 7868814
[TBL] [Abstract][Full Text] [Related]
6. Improved versus worsened endocrine function after transsphenoidal surgery for nonfunctional pituitary adenomas: rate, time course, and radiological analysis.
Jahangiri A; Wagner JR; Han SW; Tran MT; Miller LM; Chen R; Tom MW; Ostling LR; Kunwar S; Blevins L; Aghi MK
J Neurosurg; 2016 Mar; 124(3):589-95. PubMed ID: 26252454
[TBL] [Abstract][Full Text] [Related]
7. [Cushing's disease and corticotroph adenoma: anterior pituitary function before and after trans-sphenoidal microsurgery].
Martin D; Valdes-Socin H; Beckers A; Stevenaert A
Neurochirurgie; 2002 May; 48(2-3 Pt 2):226-33. PubMed ID: 12058128
[TBL] [Abstract][Full Text] [Related]
8. [Hypofunction of peripheral target-gland after radiotherapy of pituitary adenoma--an analysis of 140 cases].
Cui SX
Zhonghua Zhong Liu Za Zhi; 1990 May; 12(3):227-30. PubMed ID: 2174331
[TBL] [Abstract][Full Text] [Related]
9. Pituitary function after selective adenomectomy for Cushing's disease.
Post FA; Soule SG; De Villiers JC; Levitt NS
Br J Neurosurg; 1995; 9(1):41-6. PubMed ID: 7786425
[TBL] [Abstract][Full Text] [Related]
10. [Pituitary function after transsphenoidal surgery for pituitary adenoma].
Gołkowski F; Trofimiuk M; Huszno B; Bałdys-Waligórska A; Szybiński Z; Czepko R; Danilewicz B
Przegl Lek; 2001; 58(9):825-7. PubMed ID: 11868239
[TBL] [Abstract][Full Text] [Related]
11. The use of postoperative ACTH levels as a marker for successful transsphenoidal microsurgery in Cushing's disease.
Flitsch J; Knappe UJ; Lüdecke DK
Zentralbl Neurochir; 2003; 64(1):6-11. PubMed ID: 12582940
[TBL] [Abstract][Full Text] [Related]
12. Pre- and post-operative hypothalamic-pituitary-thyroidal axis function in patients with prolactinoma, growth hormone tumour and ACTH tumour.
Lu C; Lin XT; Yang DT; Liu YC; He WT; Zhong XL
Chin Med J (Engl); 1989 Apr; 102(4):306-12. PubMed ID: 2551602
[TBL] [Abstract][Full Text] [Related]
13. Pituitary hormonal loss and recovery after transsphenoidal adenoma removal.
Fatemi N; Dusick JR; Mattozo C; McArthur DL; Cohan P; Boscardin J; Wang C; Swerdloff RS; Kelly DF
Neurosurgery; 2008 Oct; 63(4):709-18; discussion 718-9. PubMed ID: 18981881
[TBL] [Abstract][Full Text] [Related]
14. Treatment of Cushing's disease by transsphenoidal, pituitary microsurgery: prognosis factors and long-term follow-up.
Bakiri F; Tatai S; Aouali R; Semrouni M; Derome P; Chitour F; Benmiloud M
J Endocrinol Invest; 1996 Oct; 19(9):572-80. PubMed ID: 8957739
[TBL] [Abstract][Full Text] [Related]
15. Axis-specific analysis and predictors of endocrine recovery and deficits for non-functioning pituitary adenomas undergoing endoscopic transsphenoidal surgery.
Hwang JY; Aum DJ; Chicoine MR; Dacey RG; Osbun JW; Rich KM; Zipfel GJ; Klatt-Cromwell CN; McJunkin JL; Pipkorn P; Schneider JS; Silverstein JM; Kim AH
Pituitary; 2020 Aug; 23(4):389-399. PubMed ID: 32388803
[TBL] [Abstract][Full Text] [Related]
16. FSH-producing macroadenoma associated in a patient with Cushing's disease.
Oyama K; Yamada S; Hukuhara N; Hiramatsu R; Taguchi M; Yazawa M; Matsuda A; Ohmura E; Imai Y
Neuro Endocrinol Lett; 2006 Dec; 27(6):733-6. PubMed ID: 17187002
[TBL] [Abstract][Full Text] [Related]
17. Hypothalamic-pituitary dysfunction after radiation for brain tumors.
Constine LS; Woolf PD; Cann D; Mick G; McCormick K; Raubertas RF; Rubin P
N Engl J Med; 1993 Jan; 328(2):87-94. PubMed ID: 8416438
[TBL] [Abstract][Full Text] [Related]
18. Immediate recovery of pituitary function after transsphenoidal resection of pituitary macroadenomas.
Arafah BM; Kailani SH; Nekl KE; Gold RS; Selman WR
J Clin Endocrinol Metab; 1994 Aug; 79(2):348-54. PubMed ID: 8045946
[TBL] [Abstract][Full Text] [Related]
19. Non-functioning pituitary adenomas: endocrinological and clinical outcome after transsphenoidal and transcranial surgery.
Wichers-Rother M; Hoven S; Kristof RA; Bliesener N; Stoffel-Wagner B
Exp Clin Endocrinol Diabetes; 2004 Jun; 112(6):323-7. PubMed ID: 15216450
[TBL] [Abstract][Full Text] [Related]
20. Impact of primary surgery on pituitary function in patients with non-functioning pituitary adenomas -- a study on 721 patients.
Nomikos P; Ladar C; Fahlbusch R; Buchfelder M
Acta Neurochir (Wien); 2004 Jan; 146(1):27-35. PubMed ID: 14740262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
